Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Shandong New Time Pharmaceutical Co., LTD)"
Count: 18
Selected: 0
NCT06206915Phase I Study of XZ120 in Malignant Tumors
NCT06226363Phase I Study of LNF1901 in Advanced Malignant Tumors
NCT06226350A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma
NCT06202456A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver
NCT06188611A Phase IV Study of Huazhi Rougan Granule
NCT05741021A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
NCT05740215Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors
NCT05408221the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma
NCT05305183A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis
NCT05293028Study of F527 in Patients With Relapsed or Refractory Lymphoma
NCT05178836A Phase II Study to Evaluate the Efficacy and Safety of F520 Combined With F007 in Patients With RR DLBCL
NCT05076474Pharmacodynamic Equivalence Study Of Orlistat Capsules 60 mg
NCT05040906A Study Comparing the Efficacy and Safety Between H-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients
NCT04984434Phase 1 Study of F182112 in Patients With Relapsed or Refractory Multiple Myeloma
NCT04636515A Phase Ⅱ Study of F520 in Patients With Urothelial Carcinoma
NCT04457869A Study of F520 in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Secondary Central Nervous System Lymphoma (SCNSL)
NCT04457830The Efficacy and Safety of F520 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (PTCL).
NCT03657381Phase Ⅰ Study to Evaluate the Safety and Tolerability of Using F520